2 Firmen

LimmaTech Biologics AG


8952 Schlieren, Grabenstrasse 3

 +41 44 733 85 85

LimmaTech Biologics AG is a clinical stage biopharmaceutical company focused on the development and manufacture of next generation bioconjugate vaccines using glycoengineering and protein glycosylation techniques previously developed by GlycoVaxyn and now owned by GSK. It was founded as a spin-off of GlycoVaxyn AG, which was acquired by GSK in February 2015 following a two-year collaboration. LimmaTech is developing vaccines exclusively for GSK and actively explores applications of glycoengineering and protein glycosylation technology in other fields.

LimmaTech Biologics AG

Grabenstrasse 3

8952 Schlieren

Luciole Medical AG


8006 Zürich, Weinbergstrasse 161


Luciole Medical AG is dedicated to optimizing diagnosis and treatment of patients with stroke and brain injuries in order to save and improve life and life quality.

Luciole Medical AG

Weinbergstrasse 161

8006 Zürich

Nach oben